
A Small Supplement Trial Found Better Vascular Markers After Six Months
In a small placebo-controlled trial, measures of artery dilation, stiffness and systolic blood pressure improved after six months. The trial randomized 61 adults, and 43 completed both visits.
A new editorial series
Age Old Questions
Common questions about aging, answered casually, clearly, and with science behind them.
How we report
Three ways we separate signal from noise
Choose a format to explore our analysis. Each one answers a different question about longevity science and the claims surrounding it.
01 / Evaluate the thing
Evidence Check
See what the research actually supports, how strong the evidence is, and what remains uncertain.
02 / Test the claim
Hype Check
Separate credible findings from exaggerated headlines, premature conclusions, and marketing claims.
03 / Follow the story
What Happened To…?
Revisit once-promising longevity ideas and see whether the science advanced, stalled, or changed direction.
Research & News

Inflammation in Aging Mouse Hearts Clusters Around Valves and the Aorta
Gene activity in older mouse hearts linked immune changes and scar-related signals to the valves and nearby aorta.

What a Model Can Tell Us About Aging After Breast Cancer Chemotherapy
A breast cancer simulation estimated how treatment-related cellular aging might affect long-term survival. Its life-year figures are projections.

Experimental Compound Targets Senescent Cells and Extends Lifespan in Mice
Vanadyl sulfate increased median lifespan by about 7.4% in a small study of male mice. The preliminary findings do not…
Deep Dive

Whatever Happened to Metformin as an Anti-Aging Drug?
Metformin’s longevity promise has met mixed human trial results. We trace the mouse experiments, TAME plans, exercise findings and a new frailty preprint.
Companies & Investment
Lineage Acquires an Experimental Cell Therapy Program for Huntington’s Disease
Lineage closed its NeuroAirmid acquisition on November 12. The deal adds HUNT1, a neural stem cell candidate in an early Huntington’s disease trial.







